REF-433 · ACTN3 R577X Meta-Analysis, 2024 · Sports Medicine - Open, · Paper

ACTN3 R577X polymorphism and power/endurance phenotype

Most-replicated single-gene association for athletic phenotype

A-fairly strong evidenceMeasured on a mixed groupWritten before October 2026, being re-checked

Background

ACTN3 encodes α-actinin-3, a structural protein of fast-twitch muscle fibres. The R577X polymorphism (rs1815739) gives three genotypes — RR, RX, XX; the RR genotype and R allele are associated with normal α-actinin-3 expression in fast-twitch fibres, while XX homozygotes lack the protein (the abstract states the RR/normal-expression association; the stop-codon mechanism is general genetics, not from this paper).

Methods (from the abstract)

Five databases (PubMed, Web of Science, Scopus, Science Direct, SPORTDiscus) searched to 31 December 2022
Included: studies reporting ACTN3 R577X genotype frequencies in power athletes with a comparison to endurance athletes or non-athletic controls
476 records screened → 25 studies, 13 countries, 14,541 participants; fixed or random-effects models; heterogeneity (I², Cochran's Q), publication bias and sensitivity analyses

Key Findings — Meta-Analysis Findings

1

Within power athletes the genotype order is RX > RR > XX: RR vs RX OR 0.70 (95% CI 0.57–0.85); RR vs XX OR 4.26 (3.19–5.69); RX vs XX OR 6.58 (5.66–7.67); R allele more frequent than X (OR 2.87, 2.35–3.50)

2

Power athletes vs non-athletes: RR more frequent (OR 1.48, 1.25–1.75); RX similar (OR 0.84, 0.71–1.00, p=0.06); XX less frequent (OR 0.73, 0.64–0.84); R allele more frequent (OR 1.28, 1.19–1.38); X allele more frequent in controls (OR 0.78, 0.73–0.84)

3

Power athletes vs endurance athletes: RR more frequent in power (OR 1.27, 1.09–1.49, p=0.003); RX similar (OR 1.07, 0.93–1.24, p=0.36); XX less frequent in power (OR 0.63, 0.52–0.76); R allele higher in power (OR 1.32, 1.11–1.57, p=0.002); X allele higher in endurance (OR 0.76, 0.64–0.90, p=0.002)

4

No sex difference: genotypic and allelic frequencies were similar in male and female power athletes

5

Authors' conclusion: RR genotype / R allele, tied to normal α-actinin-3 expression in fast-twitch fibres, may offer some benefit for developing muscle strength and power

Mechanism

Not from this paper (general muscle physiology): α-actinin-3 is a Z-disc protein of fast-twitch fibres; its absence in XX individuals is thought to shift fast fibres toward a more oxidative profile. The meta-analysis reports frequencies, not mechanism or performance measurements.

Practical Application

Across 25 studies and 14,541 people, the ACTN3 RR genotype is modestly over-represented in power athletes versus non-athletes (OR 1.48) and versus endurance athletes (OR 1.27), and the XX genotype is under-represented in power athletes (OR 0.73 vs controls, 0.63 vs endurance); even so, the commonest genotype among power athletes is RX — a real but small population-level enrichment, not an individual predictor
Single-gene test of modest predictive value — odds ratios of 1.27-1.48 are far from deterministic; not strong enough to redirect training
Not useful for: overruling demonstrated performance or training response; many power athletes carry XX and many endurance athletes carry RR (the abstract's ORs imply substantial overlap; exact shares are not given)
The pattern held equally in male and female power athletes

Caveats from REF-360

Genetic tests for training prescription have not shown clinical benefit over simple response testing; cannot predict individual destiny from a single SNP

Limitations

Genotype-frequency (case-control) design: enrichment at the population extreme, not a performance outcome
Genotype frequencies vary by population (13 countries pooled)
Polymorphism is one of many; polygenic scores are more predictive than a single SNP
Does NOT predict individual performance
How this entry was checked and changed
Why this level

regraded 2026-09-27 from A: meta-analysis of observational genotype-frequency comparisons across 13 countries, heterogeneity tested

Content correction 2026-09-27
"23 studies" -> 25 studies (13 countries, 14,541 participants). "OR ~1.4-1.8" and "OR ~0.5-0.7" -> replaced with the abstract's ORs and CIs.
"Endurance enrichment of XX significant in females, weaker in males" -> the abstract reports similar genotype/allele frequencies in male and female power athletes; removed.
Population genotype frequencies (~30-35% / ~50% / ~15-18%), "~1-3% performance variance", "~10-15% of sprinters XX / ~25-30% of endurance athletes RR" -> not in the abstract (and not in REF-360); removed.
Level A -> A- (meta-analysis of observational frequency studies); added Tier/Sport lines; corrected the Representative citation.
2026-09-28: added Journal line from the Europe PMC record (Europe PMC/PubMed PMID 38609671).
2026-10-01: cross-reference to SYNTH-13 no longer names an archetype — that model was retired as an unvalidated composite.